Understanding the role of GATA3 in BCC by studying its association with BCC aggressiveness will help to understand BCC pathogenesis further and open the door to further research areas and possible new treatment opportunities involving the modulation of the GATA3 pathway. This evidence concerns the gene GATA3 and skin basal cell carcinoma.